Petro Sereda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Petro Sereda has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Єлизавета Шевченко
ПВНЗ «Київський медичний університет», Україна
3 shared publications - Maryna Mykolaivna Dolzhenko
Національний університет охорони здоров’я України імені П.Л. Шупика, Київ
2 shared publications - Oleksandr Komarida
Department of Organization and Economics of Pharmacy, Bogomolets National Medical University, Kyiv, Ukraine
2 shared publications - Андрій Гудзенко
Private higher educational establishment «Kyiv Medical University
2 shared publications Ганна Володимирівна Зайченко
2 shared publicationsКостянтин Леонідович Косяченко
2 shared publications
Latest Publications
- Open Access
- 26 August 2025
- Published by The State Expert Center of the Ministry of Health of Ukraine in Farmatsevtychnyi zhurnal
- No. 4,p. 86-93
Microscopic analysis of the aerial part of potatoes (Solanum tuberosum L.)
Potato (Solanum tuberosum L.) is a widely spread food plant that contains valuable biologically active substances and mineral elements, which determine its important nutritional and medical-pharmaceutical significance. Of particular importance is the study of the epidermal structures of the plant, which perform protective, regulatory and secretory functions. The aim of this study was to microscopically examine the ultrastructure of the epidermal coverings and anatomical structure of the leaves, stems and flowers of Solanum tuberosum L., harvested during the flowering phase from potatoes grown on experimental plots at the Institute of Potato Research of the National Academy of Agrarian Sciences of Ukraine in June–July 2024. The plant material was fixed in a solution of FAA (formalin–acetic acid–alcohol). To study the ultrastructure, scanning electron microscopy was used with prior gold and platinum coating of the samples. Studies have shown that the stem of Solanum tuberosum L. is characterised by a spiny epidermal relief, complex pubescence with glandular and multicellular trichomes, a clearly defined anatomical structure, and a ring-shaped conducting system.The vascular system is ring-shaped, with small phloem elements and radially arranged xylem vessels, between which there are arrays of sclerenchymatic parenchyma. The leaf is amphistomatic, with a well-developed cuticle and dense mixed pubescence. Conductive system: single-bundle central vein with 23–25 vessels, surrounded by chlorophyll-free parenchyma. The collenchyma is adjacent to the epidermis and chlorophyll-free parenchyma. The floral organs (calyx, petals) are covered with several types of trichomes, including glandular trichomes, which are particularly common in the basal part of the petals. The surface relief of the petal epidermis is collicular in nature. The anatomical structure of the leaves, stems and floral organs of Solanum tuberosum L. is characterized by clear tissue differentiation and the presence of morphologically diverse trichomes, which are important for plant identification. The discovered features of epidermal structures, surface relief, types of pubescence and mesophyll structure can be used as diagnostic features of medicinal plant material and further identification of biologically active compounds in it.
- 26 August 2025
- Published by The State Expert Center of the Ministry of Health of Ukraine in Farmatsevtychnyi zhurnal
- No. 4,p. 86-93
Open AccessMicroscopic analysis of the aerial part of potatoes (Solanum tuberosum L.)
Potato (Solanum tuberosum L.) is a widely spread food plant that contains valuable biologically active substances and mineral elements, which determine its important nutritional and medical-pharmaceutical significance. Of particular importance is the study of the epidermal structures of the plant, which perform protective, regulatory and secretory functions. The aim of this study was to microscopically examine the ultrastructure of the epidermal coverings and anatomical structure of the leaves, stems and flowers of Solanum tuberosum L., harvested during the flowering phase from potatoes grown on experimental plots at the Institute of Potato Research of the National Academy of Agrarian Sciences of Ukraine in June–July 2024. The plant material was fixed in a solution of FAA (formalin–acetic acid–alcohol). To study the ultrastructure, scanning electron microscopy was used with prior gold and platinum coating of the samples. Studies have shown that the stem of Solanum tuberosum L. is characterised by a spiny epidermal relief, complex pubescence with glandular and multicellular trichomes, a clearly defined anatomical structure, and a ring-shaped conducting system.The vascular system is ring-shaped, with small phloem elements and radially arranged xylem vessels, between which there are arrays of sclerenchymatic parenchyma. The leaf is amphistomatic, with a well-developed cuticle and dense mixed pubescence. Conductive system: single-bundle central vein with 23–25 vessels, surrounded by chlorophyll-free parenchyma. The collenchyma is adjacent to the epidermis and chlorophyll-free parenchyma. The floral organs (calyx, petals) are covered with several types of trichomes, including glandular trichomes, which are particularly common in the basal part of the petals. The surface relief of the petal epidermis is collicular in nature. The anatomical structure of the leaves, stems and floral organs of Solanum tuberosum L. is characterized by clear tissue differentiation and the presence of morphologically diverse trichomes, which are important for plant identification. The discovered features of epidermal structures, surface relief, types of pubescence and mesophyll structure can be used as diagnostic features of medicinal plant material and further identification of biologically active compounds in it.
- Open Access
- 9 May 2025
- Published by European Scientific Platform (Publications)
- No. May 9, 202,p. 607-610
ВИЗНАЧЕННЯ КОНЦЕНТРАЦІЇ АМІНОКИСЛОТ У ЛИСТІ, КВІТКАХ ТА ПРОРОСТКАХ SOLANUM TUBEROSUM L.
Вступ. Амінокислоти — це базові структурні одиниці білків, що відіграють ключову роль у функціонуванні клітин, обміні речовин, рості та розвитку організмів. У рослинному організмі амінокислоти є не лише складовими білків, а й активними учасниками метаболічних та адаптогенних процесів, вони беруть участь у синтезі гормонів і ферментів, виконують низку інших важливих функцій. У зв’язку з цим дослідження якісного та кількісного складу амінокислот у рослинних об’єктах дає можливість глибше зрозуміти фізіолого – біохімічні процеси, що відбуваються в клітинах, оцінити біологічну цінність амінокислот, визначити оптимальні шляхи використання рослинної сировини у харчуванні людини та для потреб медицини і фармації [1,3,4].
- 9 May 2025
- Published by European Scientific Platform (Publications)
- No. May 9, 202,p. 607-610
Open AccessВИЗНАЧЕННЯ КОНЦЕНТРАЦІЇ АМІНОКИСЛОТ У ЛИСТІ, КВІТКАХ ТА ПРОРОСТКАХ SOLANUM TUBEROSUM L.
Вступ. Амінокислоти — це базові структурні одиниці білків, що відіграють ключову роль у функціонуванні клітин, обміні речовин, рості та розвитку організмів. У рослинному організмі амінокислоти є не лише складовими білків, а й активними учасниками метаболічних та адаптогенних процесів, вони беруть участь у синтезі гормонів і ферментів, виконують низку інших важливих функцій. У зв’язку з цим дослідження якісного та кількісного складу амінокислот у рослинних об’єктах дає можливість глибше зрозуміти фізіолого – біохімічні процеси, що відбуваються в клітинах, оцінити біологічну цінність амінокислот, визначити оптимальні шляхи використання рослинної сировини у харчуванні людини та для потреб медицини і фармації [1,3,4].
- Open Access
- 28 March 2024
- Published by Bentham Science Publishers Ltd. in New Emirates Medical Journal
- Vol. 05 (1) , 1-10
A Systematic Review of the Novel Targeted Immunobiological Medications in Rheumatoid Arthritis: Efficacy, Safety, and Innovation
Introduction: Over the last half-century, the treatment and management of autoimmune rheumatic diseases have progressively improved, particularly with the contribution of immunobiological or biological therapies known as disease-modifying antirheumatic drugs. Although these agents have been generally efficient in the management of rheumatoid arthritis (RA), some patients experience limited efficacy and non-responsiveness to treatment. In addition, they may cause adverse clinical effects, further aggravating the disease. Objectives: Despite advancements in biological therapies, significant clinical needs persist. This review aims to discuss novel treatments, guiding future guidelines and drug discoveries for rheumatoid arthritis. Methods: This review follows the 2020 PRISMA statement, utilising PubMed and Google Scholar for literature search and emphasizing recent meta-analyses on the safety and efficacy of targeted immunobiological medications. Results: Small molecule inhibitors, whether utilised independently or in conjunction with Methotrexate, have been shown to contribute to effective disease management and have the potential for better adherence to the American College of Rheumatology criteria. Tocilizumab therapy demonstrates a significant reduction in disease activity and improves rates of disease remission when combined with Methotrexate. Investigations of mesenchymal stromal cell therapies have had promising outcomes, improving both cartilage quality (as evaluated by Macroscopic Cartilage Repair Assessment) and joint tenderness and swelling in clinical joint counts. Intra-articular administration of tolerogenic dendritic cells has displayed a capacity to alleviate pain, as measured by Visual Analog Scale scores, and enhance the Disease Activity Score across 28 joints. Resveratrol capsules supplemented with allopathic therapy show potential in reducing TNF-α and interleukin-6 serum levels. Conclusion: More investigations and their analysis will improve patient outcomes and reduce adverse effects and the costs involved in developing and obtaining immunobiological drugs. Moreover, assessing the safety and efficacy of anti-RA properties of the bioactive compounds could offer less toxic and more cost-effective natural treatment options.
- 28 March 2024
- Published by Bentham Science Publishers Ltd. in New Emirates Medical Journal
- Vol. 05 (1) , 1-10
Open AccessA Systematic Review of the Novel Targeted Immunobiological Medications in Rheumatoid Arthritis: Efficacy, Safety, and Innovation
Introduction: Over the last half-century, the treatment and management of autoimmune rheumatic diseases have progressively improved, particularly with the contribution of immunobiological or biological therapies known as disease-modifying antirheumatic drugs. Although these agents have been generally efficient in the management of rheumatoid arthritis (RA), some patients experience limited efficacy and non-responsiveness to treatment. In addition, they may cause adverse clinical effects, further aggravating the disease. Objectives: Despite advancements in biological therapies, significant clinical needs persist. This review aims to discuss novel treatments, guiding future guidelines and drug discoveries for rheumatoid arthritis. Methods: This review follows the 2020 PRISMA statement, utilising PubMed and Google Scholar for literature search and emphasizing recent meta-analyses on the safety and efficacy of targeted immunobiological medications. Results: Small molecule inhibitors, whether utilised independently or in conjunction with Methotrexate, have been shown to contribute to effective disease management and have the potential for better adherence to the American College of Rheumatology criteria. Tocilizumab therapy demonstrates a significant reduction in disease activity and improves rates of disease remission when combined with Methotrexate. Investigations of mesenchymal stromal cell therapies have had promising outcomes, improving both cartilage quality (as evaluated by Macroscopic Cartilage Repair Assessment) and joint tenderness and swelling in clinical joint counts. Intra-articular administration of tolerogenic dendritic cells has displayed a capacity to alleviate pain, as measured by Visual Analog Scale scores, and enhance the Disease Activity Score across 28 joints. Resveratrol capsules supplemented with allopathic therapy show potential in reducing TNF-α and interleukin-6 serum levels. Conclusion: More investigations and their analysis will improve patient outcomes and reduce adverse effects and the costs involved in developing and obtaining immunobiological drugs. Moreover, assessing the safety and efficacy of anti-RA properties of the bioactive compounds could offer less toxic and more cost-effective natural treatment options.
- Open Access
- 1 January 2024
- Published by Publishing House Helvetica (Publications)
- No. 2,p. 97-100
STUDY OF THE QUALITATIVE COMPOSITION AND DETERMINATION OF THE QUANTITATIVE CONTENT OF AMINO ACIDS IN MEDICINAL PLANT MATERIALS OF SOLANUM TUBEROSUM L.
Amino acids are the basic building blocks of proteins that play a key role in cell function, metabolism, growth and development of organisms. In the plant organism, amino acids are not only components of proteins, but also active participants in metabolic and adaptogenic processes; they participate in the synthesis of hormones and enzymes, and perform a number of other important functions. In this regard, the study of the qualitative and quantitative composition of amino acids in plant objects provides an opportunity to better understand physiological and biochemical processes, to assess the biological value of amino acids, to determine the optimal ways of using plant materials in human nutrition and for the needs of medicine and pharmacy. Амінокислоти – це базові структурні одиниці білків, що відіграють ключову роль у функціону- ванні клітин, обміні речовин, рості та розвитку організмів. У рослинному організмі амінокислоти є не лише складниками білків, а й активними учасниками метаболічних і адаптогенних процесів, вони беруть участь у синтезі гормонів і ферментів, виконують низку інших важливих функцій. У зв’язку із цим дослідження якісного та кількісного складу амінокислот у рослинних об’єктах дає можли- вість глибше зрозуміти фізіолого-біохімічні процеси, що відбуваються у клітинах, оцінити біологічну цінність амінокислот, визначити оптимальні шляхи використання рослинної сировини в харчуванні людини та для потреб медицини і фармації.
- 1 January 2024
- Published by Publishing House Helvetica (Publications)
- No. 2,p. 97-100
Open AccessSTUDY OF THE QUALITATIVE COMPOSITION AND DETERMINATION OF THE QUANTITATIVE CONTENT OF AMINO ACIDS IN MEDICINAL PLANT MATERIALS OF SOLANUM TUBEROSUM L.
Amino acids are the basic building blocks of proteins that play a key role in cell function, metabolism, growth and development of organisms. In the plant organism, amino acids are not only components of proteins, but also active participants in metabolic and adaptogenic processes; they participate in the synthesis of hormones and enzymes, and perform a number of other important functions. In this regard, the study of the qualitative and quantitative composition of amino acids in plant objects provides an opportunity to better understand physiological and biochemical processes, to assess the biological value of amino acids, to determine the optimal ways of using plant materials in human nutrition and for the needs of medicine and pharmacy. Амінокислоти – це базові структурні одиниці білків, що відіграють ключову роль у функціону- ванні клітин, обміні речовин, рості та розвитку організмів. У рослинному організмі амінокислоти є не лише складниками білків, а й активними учасниками метаболічних і адаптогенних процесів, вони беруть участь у синтезі гормонів і ферментів, виконують низку інших важливих функцій. У зв’язку із цим дослідження якісного та кількісного складу амінокислот у рослинних об’єктах дає можли- вість глибше зрозуміти фізіолого-біохімічні процеси, що відбуваються у клітинах, оцінити біологічну цінність амінокислот, визначити оптимальні шляхи використання рослинної сировини в харчуванні людини та для потреб медицини і фармації.